UFP Technologies plans to report Q4 and year-end results on February 24, holding a conference call on February 25.
Quiver AI Summary
UFP Technologies, Inc. announced that it will report its fourth quarter and year-end financial results on February 24, 2026, after the stock market closes. A conference call to discuss these results will take place the following day, February 25, at 8:30 AM Eastern Time. Participants can join the call via specific dial-in numbers, and a live webcast will be available along with accompanying materials. The company specializes in developing and manufacturing single-use and single-patient medical devices, serving as an essential partner to leading medical device manufacturers. For more information, investors can visit the company's Investor Relations website.
Potential Positives
- The announcement of the fourth quarter and year-end results reporting date indicates that the company is on a regular financial reporting schedule, which may enhance transparency and investor confidence.
- The subsequent conference call allows for direct communication between the company and its investors, potentially fostering a stronger relationship with stakeholders.
- UFP Technologies is highlighted as a key partner in the medical device supply chain, reinforcing its industry importance and potential for strategic growth opportunities.
Potential Negatives
- Announcement of fourth quarter and year-end results is often seen as a critical indicator of a company's performance, suggesting that the company may be facing challenges that need to be addressed in the upcoming report.
- The timing of the earnings report after the market close may lead to negative reactions from investors anticipating bad news before the conference call.
- Failure to provide any preliminary information or guidance ahead of the earnings report may create uncertainty and concern among investors.
FAQ
When will UFP Technologies announce its fourth-quarter results?
UFP Technologies plans to report its fourth-quarter results on February 24th, 2026, after the market closes.
What time is the UFP Technologies conference call?
The conference call to discuss the results will take place on February 25th, 2026, at 8:30 AM Eastern time.
How can I join the UFP Technologies conference call?
Participants can join the call by dialing 1-412-206-6478 for USA/Canada or 1-833-890-4010 for international access.
Where can I find the UFP Technologies conference call webcast?
A live webcast of the conference call will be available on the UFP Technologies website under the Investor Relations section.
Who should I contact for investor inquiries at UFP Technologies?
Investor inquiries can be directed to Jeff Elliott at Three Part Advisors, LLC, at 214-966-9014.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$UFPT Insider Trading Activity
$UFPT insiders have traded $UFPT stock on the open market 13 times in the past 6 months. Of those trades, 0 have been purchases and 13 have been sales.
Here’s a breakdown of recent trading of $UFPT stock by insiders over the last 6 months:
- DANIEL C CROTEAU has made 0 purchases and 2 sales selling 2,873 shares for an estimated $591,883.
- CHRISTOPHER P. LITTERIO (Senior Vice President) has made 0 purchases and 10 sales selling 1,829 shares for an estimated $415,549.
- JASON HOLT (Vice President) sold 100 shares for an estimated $21,358
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$UFPT Revenue
$UFPT had revenues of $154.6M in Q3 2025. This is an increase of 6.47% from the same period in the prior year.
You can track UFPT financials on Quiver Quantitative's UFPT stock page.
$UFPT Hedge Fund Activity
We have seen 123 institutional investors add shares of $UFPT stock to their portfolio, and 172 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- THRIVENT FINANCIAL FOR LUTHERANS added 223,121 shares (+892.3%) to their portfolio in Q4 2025, for an estimated $49,539,555
- INVESCO LTD. removed 149,367 shares (-84.9%) from their portfolio in Q3 2025, for an estimated $29,813,653
- CONGRESS ASSET MANAGEMENT CO added 107,908 shares (+32.4%) to their portfolio in Q4 2025, for an estimated $23,958,813
- WASATCH ADVISORS LP added 93,640 shares (+14.6%) to their portfolio in Q4 2025, for an estimated $20,790,889
- BROWN CAPITAL MANAGEMENT LLC removed 84,437 shares (-50.2%) from their portfolio in Q4 2025, for an estimated $18,747,547
- ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC added 62,472 shares (+60.3%) to their portfolio in Q4 2025, for an estimated $13,870,658
- NEUMEIER POMA INVESTMENT COUNSEL LLC added 52,120 shares (+inf%) to their portfolio in Q4 2025, for an estimated $11,572,203
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
NEWBURYPORT, Mass., Feb. 19, 2026 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today announced that the Company plans to report results for the fourth quarter and year-end on Tuesday, February 24 th , after the close of the stock market. The Company will hold a conference call to discuss the results on the following day, February 25 th , at 8:30 AM Eastern time.
Conference Call Information:
Date:
Wednesday, February 25, 2026
Time:
8:30 AM Eastern Time
Participants may join the call using the following dial-in numbers:
- USA/Canada: Toll-Free: 1-412-206-6478
- International: 1-833-890-4010
A live webcast of the conference call and accompanying materials will be available here .
A replay of the webcast will be accessible following the event on the Company’s Investor Relations website at https://ufpt.com/investors/ .
About UFP Technologies, Inc.
UFP Technologies is a contract development and manufacturing organization that specializes in single-use and single-patient medical devices. UFP is a vital link in the medical device supply chain and a valued outsourcing partner to many of the world's top medical device manufacturers. The Company’s single-use and single-patient devices and components are used in a wide range of medical devices and packaging for minimally invasive surgery, infection prevention, wound care, wearables, orthopedic soft goods, and orthopedic implants.
Investor Contact:
Jeff Elliott
Three Part Advisors, LLC
214-966-9014
UFP Technologies Contact:
Ron Lataille, CFO
978-234-0926
[email protected]
